The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene delivery for inner ear therapy

Content Provider	Scilit
Author	Yoon, Ji Young Yang, Keum-Jin Park, Shi-Nae Kim, Dong-Kee Kim, Jong-Duk
Copyright Year	2016
Abstract	The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene delivery for inner ear therapy Ji Young Yoon,1 Keum-Jin Yang,2 Shi-Nae Park,3 Dong-Kee Kim,3 Jong-Duk Kim1 1Department of Chemical and Biomolecular Engineering, BK 21 Plus Program, Korea Advanced Institute of Science and Technology, Guseong-Dong, Yuseong-Gu, Daejeon, 2Clinical Research Institute, St Mary’s Hospital, Daejeon, 3Department of Otolaryngology – Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Dexamethasone (Dex)-loaded PHEA-g-C18-Arg8 (PCA) nanoparticles (PCA/Dex) were developed for the delivery of genes to determine the synergistic effect of Dex on gene expression. The cationic PCA nanoparticles were self-assembled to create cationic micelles containing an octadecylamine (C18) core with Dex and an arginine 8 (Arg8) peptide shell for electrostatic complexation with nucleic acids (connexin 26 [Cx26] siRNA, green fluorescent protein [GFP] DNA or brain-derived neurotrophic factor [BDNF] pDNA). The PCA/Dex nanoparticles conjugated with Arg8, a cell-penetrating peptide that enhances permeability through a round window membrane in the inner ear for gene delivery, exhibited high uptake efficiency in HEI-OC1 cells. This potential carrier co-delivering Dex and the gene into inner ear cells has a diameter of 120–140 nm and a zeta potential of 20–25 mV. Different types of genes were complexed with the Dex-loaded PCA nanoparticle (PCA/Dex/gene) for gene expression to induce additional anti-inflammatory effects. PCA/Dex showed mildly increased expression of GFP and lower mRNA expression of inflammatory cytokines (IL1b, IL12, and INFr) than did Dex-free PCA nanoparticles and Lipofectamine® reagent in HEI-OC1 cells. In addition, after loading Cx26 siRNA onto the surface of PCA/Dex, Cx26 gene expression was downregulated according to real-time polymerase chain reaction for 24 h, compared with that using Lipofectamine reagent. After loading BDNF DNA into PCA/Dex, increased expression of BDNF was observed for 30 h, and its signaling pathway resulted in an increase in phosphorylation of Akt, observed by Western blotting. Thus, Dex within PCA/Dex/gene nanoparticles created an anti-inflammatory effect and enhanced gene expression. Keywords: cell-penetrating peptide, nanoparticle, dexamethasone, gene delivery, brain-derived neurotrophic factor
Related Links	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117898/pdf https://www.dovepress.com/getfile.php?fileID=33624
Ending Page	6134
Page Count	12
Starting Page	6123
e-ISSN	11782013
DOI	10.2147/ijn.s114241
Journal	International Journal of Nanomedicine
Volume Number	11
Language	English
Publisher	Informa UK Limited
Publisher Date	2016-11-01
Access Restriction	Open
Subject Keyword	Biomaterials Brain-derived Neurotrophic Factor Cell-penetrating Peptide Dexamethasone Gene Delivery Nanoparticle
Content Type	Text
Resource Type	Article